دورية أكاديمية
أعرض في EDS

Is smokeless tobacco a healthier option in patients with AUD? A follow-up study during treatment.

التفاصيل البيبلوغرافية
العنوان: Is smokeless tobacco a healthier option in patients with AUD? A follow-up study during treatment.
المؤلفون: Lien L; Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumunddal, Norway. lars.lien@sykehuset-innlandet.no.; Department of Health and Social Science, Inland Norway University of Applied Sciences, Hamarvegen 112, 2406, Elverum, Norway. lars.lien@sykehuset-innlandet.no., Bolstad I; Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumunddal, Norway.; Department of Health and Social Science, Inland Norway University of Applied Sciences, Hamarvegen 112, 2406, Elverum, Norway., Bramness JG; Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumunddal, Norway.; Department of Clinical Medicine, UiT - Norway's Arctic University, Tromsø, Norway.; Norwegian Institute of Public Health, Oslo, Norway.
المصدر: Harm reduction journal [Harm Reduct J] 2024 Sep 20; Vol. 21 (1), pp. 173. Date of Electronic Publication: 2024 Sep 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BioMed Central, c2004-
مواضيع طبية MeSH: Tobacco, Smokeless* , Quality of Life*, Humans ; Female ; Male ; Middle Aged ; Adult ; Follow-Up Studies ; Norway ; Alcoholism/rehabilitation
مستخلص: Introduction: Smoking is negatively related to mental health, but there is a paucity of research on the relationship between the use of smokeless tobacco, such as snus, and mental health outcomes, especially in people with alcohol use disorders (AUD). The aim of the present study was to examine the development of mental distress and quality of life (QoL) among AUD patients in treatment who did or did not use snus.
Method: The study included 128 AUD patients (27% female) from three rehabilitation clinics in Eastern Norway who were interviewed at admission, at 6 weeks, and after 6 months. Patients were asked about their mental health-related problems, alcohol, and substance use, QoL, and physical activity. Information about tobacco use was gathered with the questions "Do you smoke cigarettes?" and "Do you use snus?", with follow-up questions "How often?".
Result: There were 39 current snus users (31%), of which 20 were also current smokers (dual users). Seventy-five patients (59%) were smokers only, and only 14 (11%) patients were abstainers. Those who used snus only had a lower severity of dependence score than the other groups (p < 0.05). The dual use group reported lower QoL than the no tobacco use group. In a regression model adjusted for sex and age, smokers and dual users, but not users of snus, had higher levels of mental distress and poorer QoL compared to nontobacco users (p < 0.05). There were no differences between tobacco groups at follow-ups.
Conclusion: In this study, among AUD patients, snus users reported QoL and mental distress close to that of non-smokers, indicating a lower problem load among snus users compared to smokers.
Implications: Previous studies have shown conflicting results regarding the potential harm reduction effect of snus use among patients with AUD who smoke regarding their tobacco use, quality of life and mental health problems. This study suggests that snus use could also be a viable alternative to smoking for patients with addictions.
(© 2024. The Author(s).)
References: Harm Reduct J. 2019 Nov 27;16(1):62. (PMID: 31775744)
Addiction. 1995 May;90(5):607-14. (PMID: 7795497)
Alcohol Alcohol. 2017 Jul 01;52(4):477-482. (PMID: 28525537)
BMC Public Health. 2019 Sep 13;19(1):1265. (PMID: 31519157)
BMC Psychiatry. 2021 May 11;21(1):244. (PMID: 33975577)
Addict Behav Rep. 2018 Nov 22;9:100147. (PMID: 31193769)
BMC Public Health. 2023 May 15;23(1):886. (PMID: 37189128)
J Sport Health Sci. 2018 Oct;7(4):465-472. (PMID: 30450256)
BMC Med. 2021 May 7;19(1):111. (PMID: 33957912)
Scand J Pain. 2019 Jun 12;19(4):837-841. (PMID: 31199778)
Alcohol Clin Exp Res. 2015 Oct;39(10):1989-96. (PMID: 26365044)
Tob Induc Dis. 2014 Sep 01;12(1):14. (PMID: 25191176)
Isr J Psychiatry Relat Sci. 2008;45(1):33-8. (PMID: 18604908)
Tob Control. 2023 Nov;32(6):757-768. (PMID: 35197366)
BMC Public Health. 2022 Mar 31;22(1):631. (PMID: 35361172)
Int J Environ Res Public Health. 2015 Jun 25;12(7):7185-98. (PMID: 26121189)
Subst Abuse. 2021 Jul 26;15:11782218211027124. (PMID: 34366668)
PLoS One. 2013;8(2):e57646. (PMID: 23469038)
BMJ Open. 2021 Nov 10;11(11):e050608. (PMID: 34758993)
Addiction. 2020 Jan;115(1):170-174. (PMID: 31502348)
Eur J Surg. 2002;168(2):107-13. (PMID: 12113267)
Harm Reduct J. 2022 Dec 1;19(1):131. (PMID: 36456941)
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. (PMID: 12900694)
Addiction. 2014 Jul;109(7):1154-62. (PMID: 24521070)
Int J Environ Res Public Health. 2016 Nov 09;13(11):. (PMID: 27834883)
J Subst Abuse Treat. 2022 Apr;135:108640. (PMID: 34743925)
Harm Reduct J. 2011 Sep 13;8:25. (PMID: 21914165)
Drug Alcohol Depend. 2015 Apr 1;149:151-7. (PMID: 25707707)
PLoS One. 2015 Mar 25;10(3):e0120581. (PMID: 25807109)
Nicotine Tob Res. 2018 May 3;20(6):707-713. (PMID: 28482108)
Harm Reduct J. 2021 Dec 4;18(1):123. (PMID: 34863207)
Nicotine Tob Res. 2023 Jan 1;25(1):135-142. (PMID: 36037069)
Addict Behav. 2017 Feb;65:161-170. (PMID: 27816663)
Behav Sci. 1974 Jan;19(1):1-15. (PMID: 4808738)
Tob Induc Dis. 2023 May 18;21:61. (PMID: 37215190)
Addiction. 2022 Oct;117(10):2695-2706. (PMID: 35603916)
BMC Med. 2020 Aug 12;18(1):222. (PMID: 32782007)
PLoS One. 2014 Oct 08;9(10):e108897. (PMID: 25296339)
Scand J Public Health. 2008 Jan;36(1):52-61. (PMID: 18426785)
N Z Med J. 2010 Nov 26;123(1326):129-32. (PMID: 21326410)
تواريخ الأحداث: Date Created: 20240919 Date Completed: 20240920 Latest Revision: 20240922
رمز التحديث: 20240922
مُعرف محوري في PubMed: PMC11414313
DOI: 10.1186/s12954-024-01077-9
PMID: 39300439
قاعدة البيانات: MEDLINE
الوصف
تدمد:1477-7517
DOI:10.1186/s12954-024-01077-9